Metal microdrive and head cap system for silicon probe recovery in freely moving rodent

  1. Mihály Vöröslakos
  2. Peter C Petersen
  3. Balázs Vöröslakos
  4. György Buzsáki  Is a corresponding author
  1. New York University, United States
  2. University of Copenhagen, Denmark
  3. Budapest University of Technology and Economics, Hungary

Abstract

High-yield electrophysiological extracellular recording in freely moving rodents provides a unique window into the temporal dynamics of neural circuits. Recording from unrestrained animals is critical to investigate brain activity during natural behaviors. The use and implantation of high-channel-count silicon probes represent the largest cost and experimental complexity associated with such recordings making a recoverable and reusable system desirable. To address this, we have designed and tested a novel 3D printed head-gear system for freely moving mice and rats. The system consists of a recoverable microdrive printed in stainless steel and a plastic head cap system, allowing researchers to reuse the silicon probes with ease, decreasing the effective cost, and the experimental effort and complexity. The cap designs are modular and provide structural protection and electrical shielding to the implanted hardware and electronics. We provide detailed procedural instructions allowing researchers to adapt and flexibly modify the head-gear system.

Data availability

All documentations for parts and device fabrication are included in the manuscript and supporting files, including video recordings. The same information is made public via GitHub (https://github.com/buzsakilab/3d_print_designs/tree/master/Microdrives/Metal_recoverable). Data from example electrophysiological recordings are available here (https://buzsakilab.com/wp/projects/entry/65723/).

Article and author information

Author details

  1. Mihály Vöröslakos

    Neuroscience Institute, Langone Medical Center, New York University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Peter C Petersen

    Department of Neuroscience and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  3. Balázs Vöröslakos

    Faculty of Mechanical Engineering, Budapest University of Technology and Economics, Budapest, Hungary
    Competing interests
    The authors declare that no competing interests exist.
  4. György Buzsáki

    Neuroscience Institute, Langone Medical Center, Department of Neurology, New York University, New York, United States
    For correspondence
    gyorgy.buzsaki@nyulangone.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3100-4800

Funding

National Institutes of Health (U19 NS107616)

  • György Buzsáki

National Institutes of Health (U19 NS104590)

  • György Buzsáki

National Institutes of Health (R01 MH122391)

  • György Buzsáki

Lundbeckfonden

  • Peter C Petersen

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Laura L Colgin, University of Texas at Austin, United States

Ethics

Animal experimentation: All experiments were approved by the Institutional Animal Care and Use Committee at New York University Medical Center (protocol number: IA15-01466).

Version history

  1. Received: December 16, 2020
  2. Accepted: May 18, 2021
  3. Accepted Manuscript published: May 19, 2021 (version 1)
  4. Version of Record published: June 4, 2021 (version 2)

Copyright

© 2021, Vöröslakos et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 6,130
    Page views
  • 573
    Downloads
  • 16
    Citations

Article citation count generated by polling the highest count across the following sources: PubMed Central, Crossref, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Mihály Vöröslakos
  2. Peter C Petersen
  3. Balázs Vöröslakos
  4. György Buzsáki
(2021)
Metal microdrive and head cap system for silicon probe recovery in freely moving rodent
eLife 10:e65859.
https://doi.org/10.7554/eLife.65859

Share this article

https://doi.org/10.7554/eLife.65859

Further reading

    1. Neuroscience
    Kiwamu Kudo, Kamalini G Ranasinghe ... Srikantan S Nagarajan
    Research Article

    Alzheimer’s disease (AD) is characterized by the accumulation of amyloid-β and misfolded tau proteins causing synaptic dysfunction, and progressive neurodegeneration and cognitive decline. Altered neural oscillations have been consistently demonstrated in AD. However, the trajectories of abnormal neural oscillations in AD progression and their relationship to neurodegeneration and cognitive decline are unknown. Here, we deployed robust event-based sequencing models (EBMs) to investigate the trajectories of long-range and local neural synchrony across AD stages, estimated from resting-state magnetoencephalography. The increases in neural synchrony in the delta-theta band and the decreases in the alpha and beta bands showed progressive changes throughout the stages of the EBM. Decreases in alpha and beta band synchrony preceded both neurodegeneration and cognitive decline, indicating that frequency-specific neuronal synchrony abnormalities are early manifestations of AD pathophysiology. The long-range synchrony effects were greater than the local synchrony, indicating a greater sensitivity of connectivity metrics involving multiple regions of the brain. These results demonstrate the evolution of functional neuronal deficits along the sequence of AD progression.

    1. Medicine
    2. Neuroscience
    Luisa Fassi, Shachar Hochman ... Roi Cohen Kadosh
    Research Article

    In recent years, there has been debate about the effectiveness of treatments from different fields, such as neurostimulation, neurofeedback, brain training, and pharmacotherapy. This debate has been fuelled by contradictory and nuanced experimental findings. Notably, the effectiveness of a given treatment is commonly evaluated by comparing the effect of the active treatment versus the placebo on human health and/or behaviour. However, this approach neglects the individual’s subjective experience of the type of treatment she or he received in establishing treatment efficacy. Here, we show that individual differences in subjective treatment - the thought of receiving the active or placebo condition during an experiment - can explain variability in outcomes better than the actual treatment. We analysed four independent datasets (N = 387 participants), including clinical patients and healthy adults from different age groups who were exposed to different neurostimulation treatments (transcranial magnetic stimulation: Studies 1 and 2; transcranial direct current stimulation: Studies 3 and 4). Our findings show that the inclusion of subjective treatment can provide a better model fit either alone or in interaction with objective treatment (defined as the condition to which participants are assigned in the experiment). These results demonstrate the significant contribution of subjective experience in explaining the variability of clinical, cognitive, and behavioural outcomes. We advocate for existing and future studies in clinical and non-clinical research to start accounting for participants’ subjective beliefs and their interplay with objective treatment when assessing the efficacy of treatments. This approach will be crucial in providing a more accurate estimation of the treatment effect and its source, allowing the development of effective and reproducible interventions.